Introduction
Identifying the primary subset of cell types or states and genes involved in complex traits is critical to the process of developing mechanistic insights. For example, knowledge that FTO (MIM: 610966) acts on IRX3 (MIM: 612985) and IRX5 (MIM: 606195) primarily in human adipocyte progenitor cells enabled researchers to rigorously define a novel thermogenesis pathway central for lipid storage and obesity. 1 And, focusing on distinct human human C4A (MIM: 120810) and C4B (MIM: 120820) isotypes, Sekar et al. highlighted the role of the classical complement cascade (of which C4 genes are a critical component) and synapse elimination during development in the brains of individuals with schizophrenia. 2 In addition to estimating disease risk for individual variants, genome-wide association studies (GWASs) have proven useful for identifying trait-relevant cell types or tissues. Assuming that variants affect phenotypes through gene regulation, one can prioritize cell types for further analysis with an enrichment of GWAS signal in cell-typespecific functional genomic regions that affect gene regulation. A series of studies have identified enrichment of GWAS signal in sorted cell-type-specific 3 or tissue-specific 4 expression quantitative trait loci (eQTLs). Other approaches (e.g., assay for transposase-accessible chromatin using sequencing [ATAC-seq], chromatin immunoprecipitation sequencing [ChIP-seq] , and RNA sequencing
[RNA-seq]) have revealed an enrichment of GWAS signal in cell-type-specific functional annotations. [5] [6] [7] [8] [9] [10] [11] However, these analyses are limited in cell-type resolution because they either require samples with population variation (which are infeasible to collect for many cell types) or rely on functional assays that require thousands of cells (which are challenging to collect for rare or uncharacterized cell types). Thus, it remains difficult to evaluate whether disease phenotypes are driven by tissues, broad cell populations, or very specific cell types. Furthermore, an inability to analyze difficult-to-characterize cell types is a concern when scanning for links between traits and cell types in complex tissues composed of many heterogeneous cell types. For example, describing the brain as the primary pathogenic tissue responsible for schizophrenia or Alzheimer disease (AD) is unsatisfying, but it remains difficult to comprehensively collect functional information from the plethora of brain cell types necessary for standard GWAS enrichment analyses.
Meanwhile, single-cell gene expression technology has offered insights into complex cell types. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Additionally, concerted efforts are underway for the development of comprehensive single-cell atlases of complex human tissues known to be associated with phenotypes of interest, such as immune cell types for autoimmune disease and brain cell types for neuropsychiatric disorders. 22 However, to our knowledge, no existing methods are designed to link novel single-cell-based cell types and phenotypes of interest.
Thus, we developed RolyPoly, a model for prioritizing trait-relevant cell types observed from single-cell gene expression assays. Importantly, RolyPoly takes advantage of polygenic signal by utilizing GWAS summary statistics for all SNPs near protein-coding genes, appropriately accounts for linkage disequilibrium (LD), and jointly analyzes gene expression from many tissues or cell types simultaneously. Additionally, our model can utilize signatures of cell-specific gene expression to prioritize trait-relevant genes. Finally, we provide a fast and publicly available implementation of the RolyPoly model.
Material and Methods

Overview of the Methods
The primary goals of RolyPoly are to identify and prioritize traitrelevant cell types (or tissues) and genes ( Figure 1 ). Similar models have been developed to identify functional annotations important for complex traits. 7, 11 However, unlike RolyPoly, these methods focus on SNPs rather than genes. They require binary input (e.g., whether or not a SNP is associated with a functional annotation) instead of quantitative measurements (such as gene expression). The most closely related method that focuses on genes lacks an underlying model and does not take advantage of the signal from SNPs that do not meet the stringent genomewide significance threshold, potentially resulting in reduced power. 10 We decided to take a highly polygenic modeling approach to allow for the possibility that many genes might contribute to the trait. [24] [25] [26] At a high level, RolyPoly starts by learning about the relationship between gene expression and estimated GWAS effect sizes from a trait of interest (captured with our g model parameters, described below). For example, we might expect to observe larger GWAS effect sizes for cholesterol regulation at SNPs that affect liver-specific gene expression because the liver is known to regulate cholesterol levels. Thus, on the basis of such an enrichment, RolyPoly would learn that the liver is a trait-relevant tissue. Next, we can use this knowledge to prioritize trait-relevant genes by calculating a score (represented by h gene j , defined below) that identifies genes upregulated in RolyPoly-inferred relevant tissues. Continuing with our example, once we know that liver-specific gene expression is associated with larger GWAS effect sizes, RolyPoly would prioritize studying liver-specific genes in the context of understanding cholesterol regulation (resulting in larger h gene j values). Below, we describe the details of how RolyPoly carries out each of these steps.
GWAS Summary Statistics
Consider a fully polygenic GWAS model, ) (B) From a database of functional information (such as tissue or cell-type RNA-seq), we learn a regression coefficient ðb g k Þ that captures each annotation's influence on the variance of GWAS effect sizes. A deviation from the mean gene expression value of a jk results in an increase of a jk b g k to the expected variance of gene-associated GWAS effect sizes. The value b g 0 represents a regression intercept that estimates the population mean variance. To check learned model parameters, we expect to see an enrichment of LD-informed GWAS gene scores for genes that are specifically expressed in a tissue inferred to be trait relevant. Finally, from a model fit, we can prioritize traitrelevant tissues and genes.
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where R is the sample LD matrix (i.e., r ii 0 is the Pearson correlation values between genotype i and i 0 ). We used this definition of estimated GWAS effect sizes to develop a highly polygenic approach that models the variance of these SNP effect sizes as a function of annotation specificity of proximal gene expression.
Polygenic Model
For notational convenience, let g(i) represent the gene associated with SNP i and S j ¼ {i: g(i) ¼ j} be the set of SNPs associated with gene j. We use the notation b S to denote the b coordinates whose indices lie in set S. We assumed a priori that the true GWAS effect sizes of SNPs in gene j follow the normal distribution b Sj $ MVNð0; t j IÞ, where I is the S j 3 S j identity matrix and t j is the prior effect-size variance for all SNPs associated with gene j and is modeled as a linear function. More specifically, t j is a linear function of N annotations a jk (in this case, cell-type-specific gene expression) with annotation coefficients g k and an intercept term g 0 :
RolyPoly estimates the parameter vector g, which captures the influence of cell-type-specific gene expression on the variance of GWAS effect sizes (see Figure 1B) . Intuitively, if we estimate a large coefficient for annotation k, then we expect larger GWAS effect sizes around genes that are specifically expressed in annotation k. On the other hand, it is possible to estimate negative values for some annotation coefficients g. SNPs proximal to genes that are specifically expressed in an annotation with a negative g estimate are expected to have lower effect-size variance than the population mean.
According to this polygenic model, the expected value of the vector of GWAS effect sizes around gene j is E½ b b Sj ¼ 0, and the covariance matrix is given by V½ b
R Sj denotes the principal R submatrix indexed by the SNPs in S j (see Appendix A for derivation). This model assumes that the effect size of each SNP around a gene j is drawn from a distribution with a mean of 0 and the same per-SNP variance of t j . However, we expected other SNP annotations to affect the variance of a GWAS effect size, such as the minor allele frequency (MAF) of the SNP.
Therefore, we included P SNP-level features as covariates while estimating the variance contribution of gene expression. Specifically, we modified our model to use a per-SNP variance n i for SNP i, given by
where t gðiÞ is the previously described (Equation 2) contribution of gene-level annotations to the variance of SNP i, b il is the i th value of SNP-level annotation l for SNP i, and f l is the annotation coefficient for annotation l. The distribution for the vector of SNP effects associated with a gene becomes
where 28 We chose a 10 kb window centered on the transcription start site (TSS) of a gene because previous work has found that, across a diverse set of cell types and tissues, most eQTLs consistently lie in this region. [29] [30] [31] [32] During initial analysis, we observed similar parameter estimates and strength of associations by using a larger window size of 20 kb ( Figure S1 ). Thus, for computational convenience, we used a smaller 10 kb window size for results in this study. However, the model description as presented generalizes to larger window sizes or alternative approaches of SNP-gene association. One could rely on enhancer or chromatin maps from ENCODE to incorporate potentially functional variants that are farther away from the TSS. However, doing so would bias our analysis toward well-characterized cell types; thus, we did not include distal elements. With this definition of SNP-gene association, there are a few SNPs with multiple associated genes. We duplicated these SNPs and treated them as independent SNP-gene pairs. Because RolyPoly infers parameters from hundreds of thousands of SNPs, we do not expect this to contribute significantly to inferred parameters.
Parameter Inference
To perform maximum-likelihood inference under our model, we would have to compute the determinant and inverse of the potentially high-dimensional covariance matrices involved in Equation 4 , which would be computationally challenging. Instead, we adopted a method-of-moments approach in which we fit the gene-level annotation coefficients g k and, if included, the SNP-level annotation coefficients f l . Our model allows for explicit formulas to be derived for the method-of-moments estimators, which also greatly improves computational efficiency and avoids convergence concerns that are common with other inference approaches, such as expectation-maximization. If only gene-level annotations are used, we fit the observed and expected sum of squared SNP effect sizes associated with each gene, where the expected value is given by
where Tr represents the trace of a matrix (derivation in Appendix A). We derived this expectation while recognizing that the expected value of the squared [ 2 norm of a mean 0 multivariate normal distribution is the trace of the covariance matrix. When we included SNP annotation coefficients such that each SNP effect size had a variance term n i , we performed inference by fitting the observed and expected squared effect size of each SNP, where the expected value is given by
where j ¼ g(i) and ðR Sj D Sj R Sj Þ ii is the diagonal element of the matrix corresponding to SNP i. Interestingly, by using an indicator function rather than quantitative features, this model relates to previous work 33 (described in the Appendix A). We performed block bootstrap 34 to estimate standard errors, b s g k , which we used to compute a t-statistic, b g k =b s g k , and corresponding p values. We used a t-statistic because we used our bootstrap estimate of the standard error rather than a known value. The purpose of the block bootstrap is to maintain correlations present in the data when sampling from the empirical distribution; thus, we partitioned the genome into 100 non-overlapping blocks and sampled from these blocks with replacement. 35 Additionally, from the bootstrap parameter estimates, we calculated empirical 95% confidence intervals for each b g k . Unless otherwise specified, for our analyses we performed 10 3 block bootstrap iterations. After including an intercept term, b g 0 , we ranked tissues by strength of association with the t-statistic or corresponding p value. As in standard regression, the intercept term estimates the population mean of the response term, which in this case is the per-SNP variance of a GWAS effect size.
Computing Trait-Relevance Gene Importance Scores and the Proportion of Variance Explained by Individual Annotations
Using a set of inferred gene annotation coefficients, b g, we calculated several quantities that summarize the contributions of gene annotations to the phenotypic variance. First, we computed h
, which can be used to rank trait-relevant genes. Essentially, h gene j is a gene-expression-based prediction of the variance parameter for gene j of a normal distribution from which cis-GWAS effect sizes are drawn ( Figure 1B ). Thus, if h gene j is large, we would expect larger cis-GWAS effect sizes. Note that this value does not directly rely on GWAS effect-size estimates. Instead, h gene j relies on GWASs indirectly through the RolyPoly-inferred parameters. Additionally, we calculated the contribution of an annotation k to a trait as h , we compared them with gene importance estimates based on cis-GWAS summary statistics and LD information. This gene score is an estimate of the variance of GWAS effect sizes after inflation due to local LD is accounted for; thus, we refer to it as the LD-informed gene score. For this calculation, we used the methodology described in Lamparter et al. 36 and Liu et al. 37 However, we used the same window size around a gene as was used for RolyPoly. In addition to validating h gene j , we used the LD-informed gene score to verify GWAS enrichment in specifically expressed genes of model-identified traitrelevant tissues (i.e., quantile-quantile [Q-Q] plots in the Results).
If the main objective is to compute gene values, h gene j , and unbiased parameter estimates are not required, then we include a penalty on the [ 1 norm of the annotation coefficients. The penalty strength is modulated with a l tuning factor, which is chosen on the basis of cross validation. Regularization has the beneficial effect of shrinking parameter estimates of irrelevant tissues and can result in more accurate gene-score prediction.
Simulation Setup
For clarity, we denote generated parameters and data with an asterisk. In simulation results reported, we used 2 3 10 4 genes, five simulated gene annotations, and one simulated SNP annotation. We generated gene expression, a*, from a standard c 2 distribution and generated allele frequency as an example SNP annotation, b*, from a standard uniform distribution. Recall that our model annotation coefficients determine the influence that these annotations will have on SNP effect sizes. For each simulated dataset, we fixed annotation effects by sampling from a uniform distribution: f Ã $ uniformð0; 10 À5 Þ for SNP annotation effects and g Ã k $ uniformð0; 10 À5 Þ for gene annotation effects. We combined the simulated functional information and annotation coefficients to calculate a per-SNP variance term. Thus, for each SNP effect, we computed n
We combined this per-SNP variance term with a per-SNP environmentalerror contribution set to s 2 e n À1 ¼ 10 À4 to arrive at the distribution from which we generated simulated effects,
where D* is a diagonal matrix with simulated per-SNP variance values. From this distribution, for each simulated gene, we sampled 20 SNP effects. As input, our inference model takes SNP effects, environmental errors (here set to 10
À4
), and annotations and attempts to identify the true annotation effects. From this setup, we determined whether our method implementation could accurately infer generated SNP annotation effects, f Ã l , and gene annotation effects, g Ã k .
Although our method assumes that each SNP effect size is drawn from the model distribution, it is likely that some GWAS effect sizes come from a null distribution. To test robustness to this potential model misspecification, we first sampled per-gene Bernoulli random variables, p j $ BernoulliðcÞ, where c represents the fraction of causal genes (causal here simply implies sampling from the non-null model). We sampled SNP effects for each gene as
Varying the fraction of causal genes (parameter c) across simulated datasets, we studied its effect on model inference.
Obtaining Gene Expression Databases and GWAS Summary Statistics
We estimated annotation parameters for three gene expression databases. (1) 16 and age-related cognitive decline (ACD). 15 We restricted our analysis to the autosomes, removed the major histocompatibility complex (MHC) region for immune traits (chr6: 25-34 Mb), and removed rarer variants (MAF < 1%). We removed rare variants to ensure that the common variant model fit the data appropriately. For late-onset AD and ACD, in addition to using the entire set of GWAS summary statistics, we ran RolyPoly after removing variants from a 1 Mb window centered on the TSS of APOE (MIM: 107741; chr19: 44,909,011-45,909,011). All referenced genome coordinates are from UCSC Genome Browser build hg19.
Differential Gene Expression Analysis
For the analysis of h gene j enrichment in differentially expressed (DE) genes of individuals with AD, we downloaded microarray gene expression data from 230 samples of the prefrontal cortex. 51 We used Limma to analyze differential gene expression between case and control tissues. 52 We mapped probes to genes by using a mapping downloaded from Ensembl's BioMart. 46 If multiple probes mapped to a single gene, we took the median expression value across all probes. Unless otherwise specified, we performed Kolmogorov-Smirnov significance tests of gene-value enrichment within DE genes.
Calculating RolyPoly Gene-Score Enrichment while Accounting for Correlations among Gene Expression Values
To assess the enrichment of RolyPoly gene scores among DE genes, we calculated Spearman's rank-correlation coefficient, r obs , between RolyPoly gene scores and differential-expression t-statistics. A large r obs value indicates enrichment of large RolyPoly gene scores among DE genes. Assessing the significance of r obs by independently considering each gene is anti-conservative because of the correlation between gene expression levels of co-regulated genes. Therefore, we generated an empirical sampling distribution for r under the null of no association between RolyPoly scores and t, which accounted for gene expression correlation.
We estimated the variance-covariance matrix of gene expression in healthy individuals, S. Because there were fewer samples than genes, we used singular value decomposition (SVD) to represent the low-rank S matrix. Under the null hypothesis, we generated
of affected individuals, A (of equal size to the true data). For each gene j, we computed a t-statistic by testing the difference between the means of the healthy and affected simulated expression values,
where x j is the mean expression of gene j, s j is the sample variance, and n is the sample size. We computed Spearman's correlation coefficient, r sim , between t j and h gene j
. We repeated the process of generating expression and calculating r sim 10 3 times to generate a null distribution, which we then used to evaluate the significance of r obs .
Calculating LD Correlation Values
We downloaded phase 3 VCFs of European individuals from the 1000 Genomes Project. 28 We used PLINK v.1.90b1b to calculate
Pearson's r values of SNPs within the default 1 Mb window.
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RolyPoly Implementation and Usage
We implemented our method for use through the rolypoly R package, which is freely available and open source via CRAN and at our Git repository (see Web Resources).
Results
Simulation
We used simulations (see Material and Methods) to verify our implementation of RolyPoly and characterize properties of parameter estimation and hypothesis testing. Across 500 data simulations, we found that RolyPoly-inferred b g k parameters were unbiased estimates of the true underlying effect g Ã k (see Figure 2A) . This is an important property if we aim to accurately quantify the total contribution of an annotation to a trait, h annot k $h annot k summarizes the amount of signal present in the dataset to detect an association between the trait and annotation k. In particular, our power is strongly dependent on h annot k (see Figure 2B) , where power refers to the probability that we correctly reject the null hypothesis (i.e., b g < 0). It is likely that some fraction of GWAS effect sizes are drawn from a null distribution, which we do not currently model in RolyPoly. Thus, we investigated the effect of varying the fraction of GWAS effects drawn from the model distribution and our power to detect significant annotations. As expected, when the fraction of genes simulated from the causal distribution decreases, we lose power (see Figure 2B ). However, even with 25% of genes (and downstream GWAS effect sizes) drawn from the causal distribution, we achieve greater than 50% power for an annotation with h For data generated under the model, we demonstrated that our estimated parameters are unbiased and have low levels of deviation around the true parameter values. Our power to detect significant annotations is modulated by the annotation effect, the annotation values, and the fraction of effects drawn from the model distribution. Furthermore, in the setting where the effects are simulated from a mixture of the model and null distribution, we still have power to detect significant annotations.
Trait-Relevant Tissues Identified from GTEx Data
As a proof of principle, we ran our method on trait-association data from publicly available GWAS traits and gene expression data from 27 tissues of 544 individuals from the GTEx project (data download and processing are described in the Material and Methods).
In Table 1 , we summarize the top two tissue-trait associations that passed a marginal significance threshold (p < 0.05) for seven GWAS traits. With a GWAS of extreme BMI, we found associations with kidney (p ¼ 7 3 10
À3
) and thyroid (p ¼ 0.03) gene expression. Obesity is known to negatively affect kidney function; however, from existing literature, it is ambiguous whether the tissue has a causal role in determining BMI. 55 Some studies have demonstrated a correlation between thyroid function and weight. 56, 57 Others have observed a link between BMI and brain gene expression. 58, 59 We suspect that we did not observe such an association because we composed the GTEx brain annotation by aggregating gene expression across all 13 collected brain tissues (this was the most heterogeneous tissue annotation collected). We observed a significant enrichment of EA signal for genes specifically expressed in the pituitary gland (p ¼ 0.03) and brain (p ¼ 0.04), which corresponds with recent analysis. 49, 60 For height, we detected an association with muscle (p ¼ 6 3 10
À10
) and pituitary (p ¼ 6 3 10
À7
). Interestingly, tumors in the pituitary are known to lead to gigantism, characterized by excessive growth and height. 61 Finally, for several metabolic traits (TC, LDL, TG, and HDL), we detected signals for the liver, small intestine, and adrenal gland, all of which follow known biology. Next, we examined the TC GWAS, 23 given that its association with liver has been unambiguously reported in the literature. For inference, we used 121,312 SNPs that were within 5 kb of a protein-coding gene. With p values from our model, we ranked tissues by the strength of association with TC (Figure 3, left) . As expected, liver was the clear topassociated annotation (p ¼ 2 3 10 À4 ), and we estimated an annotation coefficient of 4 3 10 À6 (Figure 3, right) . Thus, we estimated that the variance of TSS-proximal GWAS effect sizes increases by 4 3 10 À6 as normalized gene expression in the liver increases by one unit (see Material and Methods for a description of gene expression normalization). The small intestine was marginally associated (p ¼ 0.01), which follows from the fact that this organ has a central role in nutrient absorption. Additionally, we observed some signal for spleen (p ¼ 0.04) and adrenal gland (p ¼ 0.05). Although the spleen is primarily thought of as an immune organ, studies have shown a clear link between splenectomy and lipid metabolism. 62 Whereas the p value for adrenal gland was identified with a q-value of 0.3, the 95% confidence interval showed a wide distribution of non-zero parameter estimates of large positive effect. Considering that the adrenal gland plays a central role in the production of hormones (many of which are synthesized from cholesterol or even have an effect on cholesterol levels), this association is biologically plausible. 63 We wanted to verify that GWAS effect sizes were enriched with association signal near genes that were specifically expressed in tissues with RolyPoly annotation coefficients significantly greater than 0. First, we calculated LD-informed gene scores, which estimate the variance of GWAS effect sizes from a cis window around each gene while accounting for LD (see Material and Methods). Next, we visualized the enrichment of these scores in specifically expressed gene sets by using Q-Q plots (Figure 4) . To define the set of tissue-specific genes, we sorted A B normalized expression values for the tissue of interest and identified the top 20% of genes as the tissue-specific gene set. Correspondingly, we refer to the bottom 20% of genes sorted by expression as the control set. We observed clear enrichment of TC cis-GWAS signal within the set of genes that were upregulated in the liver ( Figure 4A ). As a negative control, we employed the same Q-Q plot approach to determine whether there was GWAS signal around genes specifically expressed in a tissue not found to contribute significantly to TC. Within specifically expressed genes of the skin tissue ( Figure 4B ), we did not observe an enrichment of GWAS signal.
Neuropsychiatric Diseases and Single-Cell Gene Expression
We next analyzed cell types identified from publicly available single-cell expression data from the human brain 39 and several neuropsychiatric traits: ACD, late-onset AD, EA, and schizophrenia. In total, we used 477 human single cells from which gene expression data had been collected. Using a principal-component analysis (PCA)-based clustering approach, the original authors grouped the single cells into six primary cell types and two clusters of fetal cortical cells representing quiescent and replicating cell states. For each gene, we averaged gene expression counts for all cells within a cell-type cluster, thus reducing the noise across single-cell measurements (see Material and Methods). Using our model, we tested the association between each of the traits and eight clustered cell types ( Figure 5 ).
ACD is a trait characterized by a decline in cognitive capability and decreases in brain volume, both thought to be normal functions of aging. However, evidence suggests that the rate at which cognitive decline occurs is a precursor to late-onset AD, hinting at a shared genetic architecture. 64 Thus, we were interested in whether significant overlap of trait-associated cell types existed between the two traits. For ACD, we observed a significant association with fetal quiescent cells (p ¼ 0.03), which primarily consist of neurons. Quiescent fetal cells differ from replicating fetal cells in that they have begun to downregulate neuronal growth factors such as EGR1. 39 On the other hand, we found an association between AD and microglia (p ¼ 0.03) and astrocytes (p ¼ 0.03) but no enrichment for fetal neurons (p ¼ 0.8). To rule out an association driven by the APOE locus, we reran RolyPoly while removing a 1 Mb window centered on the APOE TSS. The significant microglia association persisted (p ¼ 0.03), whereas the astrocyte association did not (p ¼ 0.1). Thus, although the connection between astrocytes and AD is well studied, 65 this connection appears to be driven by few loci of large effect. Notably, there is mounting evidence for a more central role of microglia in AD; 66,67 our analyses provide genetic evidence in humans to support this hypothesis. Additionally, our results suggest a role for microglia in AD but not ACD. This finding is consistent with recent work demonstrating that although lipid regulation pathways are enriched with GWAS signal for both traits, immune pathways tend to show AD-specific signal. 68 Therefore, one could hypothesize microglial involvement during the transition between ACD and AD. For schizophrenia, we found a significant relationship with oligodendrocytes (p ¼ 0.02) and fetal replicating cells (p ¼ 0.01). The genetic basis of schizophrenia is even less well understood than that of AD, but there is a significant body of literature on oligodendrocyte dysfunction and schizophrenia. 69, 70 Moreover, recent genetic association studies have shown an enrichment of schizophrenia GWAS signal within pathways of development. [71] [72] [73] To validate these associations between traits and singlecell cell-type clusters, we processed a single-cell dataset (see Material and Methods) from mouse brains, 20 which included seven major brain cell types that had been previously identified. Because it includes only one-to-one human and mouse orthologs, we consider this dataset to be an independent pseudo-human-brain single-cell dataset. Thus, we used this dataset to validate our previous findings. We limited our analysis to cell types overlapping between the human and mouse datasets; these included microglia and oligodendrocytes. For AD, we replicated the significant association with microglia (p ¼ 0.01). Of note, there was a cluster that included astrocytes and ependymal cells; however, there was no significant association with this cluster. With schizophrenia, there was a suggestive association with the mouse-derived oligodendrocyte celltype cluster (p ¼ 0.09). Thus, from our analysis of mouse single-cell data, we replicated two of our initial trait and cell-type associations. Furthermore, we demonstrated that if human data are not available, one could swap in similar mouse data to guide initial analyses. 23 and EA, educational attainment. 49 We also ran another closely related method, snpSEA, 10 on these data. This method also integrates gene expression with GWAS and aims to identify relevant tissue or cell types. However, it does not take advantage of genomewide polygenic signal, and therefore its power is reduced. As a result, snpSEA identified an association between microglia and AD in humans but not in mice ( Figure S2 ).
RolyPoly Gene Scores Correlate with DE Genes in Individuals with AD
We were interested in studying whether RolyPoly-inferred model parameters could predict trait-relevant genes from an independent dataset. Thus, we downloaded and processed gene expression data from human prefrontal cortex samples of 101 control individuals and 129 individuals with AD (see Material and Methods and Zhang et al. 50 ).
A total of 9,228 genes were DE with a q-value < 0.1% (6,324 genes did not meet this threshold). Such a differential-expression study represents a data-driven approach to identifying AD-associated genes (independently from GWAS results). Additionally, we used summary statistics from this experiment to test the ability of our model parameters to identify trait-relevant genes.
To establish a baseline, we tested the enrichment of LD-informed gene-score estimates within DE genes. We computed these values by taking the variance of GWAS effect sizes As a first step to incorporating information from RolyPoly-inferred model parameters, we tested whether genes that were specifically expressed in a RolyPoly-inferred trait-relevant cell type were enriched with larger differential-expression test statistics. We identified the top 10% of genes specifically expressed in the microglia cell type (which our model identified as significantly associated with AD). Compared with a control set of genes, this set of genes showed a significant (p ¼ 1 3 10
À8
) enrichment of positive values of the differential-expression test statistic ( Figure 6A, right) . We performed a similar analysis with a cell type for which RolyPoly did not find evidence of AD association. There was no enrichment of DE summary statistics within the set of genes specifically expressed in fetal quiescent cells ( Figure 6A, left) .
From these observations, we reasoned that we could rank the trait relevance of genes on the basis of RolyPolyinferred parameter estimates, b g, and gene expression. As an example for AD, a gene that is specifically expressed in microglia and astrocytes would be ranked higher than a housekeeping gene. Thus, we defined the RolyPoly trait-relevance gene score h À18 ; Figure S3 ). However, it is possible that correlations among co-regulated genes could result in uncalibrated p values. Therefore, we designed a test that accounts for the covariance structure between genes (see Material and Methods values (see Figure 6B ). For validation, we were interested in replicating our enrichment of h gene j in DE genes in an independent dataset. Sekar et al. performed laser-capture microdissection to isolate astrocytes from ten healthy control individuals and individuals with AD and then identified 227 DE genes. 74 Of those genes, we predicted RolyPoly gene scores for 150 (70 of the 227 genes were not annotated as protein coding; therefore, they were not measured in the single-cell experiment). We replicated our previous result and identified a significant (p ¼ 1 3 10
À3
) enrichment within DE genes ( Figure S4 ). We were unable to perform our enrichment test that accounts for gene correlations because gene expression data were not available for this dataset.
Thus, we conclude that from GWAS and gene expression data of healthy individuals, our model parameters capture information about the relevance of a gene to a trait on the basis of which cell types express the gene. Still, we cannot discount the possibility that observed enrichments of differential-expression test statistics are a result of changes in cell-type proportions. However, in such a scenario, we would have identified trait-relevant cell types that increase or decrease in proportion and thus would be consistent with our conclusion about RolyPoly parameters.
Discussion
We have described a polygenic model for analyzing singlecell gene expression and GWAS summary statistics. Our results demonstrate that we can identify trait-relevant cell types from complex tissues and prioritize genes for further analysis.
Here, we discuss the following assumptions underlying RolyPoly: (1) we focused on cis-GWAS effects (as opposed to trans) because cis-SNPs tend to more consistently have genome-wide effects, and larger effects, on the regulation of gene expression. 31, [75] [76] [77] [78] . Even with these model assumptions, our results are well supported by known biology, as shown in the analysis of tissues and brain cell types. This is a promising step toward connecting single-cell gene expression and GWAS summary statistics to identify relevant cell types and genes. Although there is evidence linking the immune system and microglia to AD in mice, 66 we have identified an enrichment of genetic trait-association signal near genes specifically expressed in human microglia. More generally, single-cell technologies represent an opportunity to discover and characterize novel cell types and cell states. 22 Thus, there is a need for methods, such as RolyPoly, that can prioritize novel cell types relevant to human phenotypes for further study. Here, we focused on single cells clustered into cell types; however, numerous alternative groupings could be examined. For example, during cell stimulation, there exists significant cell heterogeneity even within classical marker-defined immune cell populations. 79, 80 Using RolyPoly, one could link these novel subpopulations to autoimmune disease phenotypes. These analyses should increase only as single-cell data become more commonly available. It is challenging to pinpoint causal genes from GWASs because LD-related correlations among SNP effects A B confound the identification of causal variants. Moreover, it is difficult to identify the target gene modulated by a regulatory variant. Statistical methods that integrate GWASs and eQTLs while accounting for the effects of LD 81, 82 have proven useful. However, the eQTL data might not be specific to the disease-relevant tissue or cell type. To supplement these approaches, we suggest using the signature of gene expression and parameters from our model to prioritize genes proximal to significant GWAS variants for further analysis. Consider a region with complex LD structure and significant trait-association signal; ideally, one would rely on overlapping eQTL information to identify the causal SNP and gene.
But, without knowledge of the causal tissue, GWASeQTL overlap with a non-causal tissue could be misleading and complicate the task of collecting relevant eQTL information. Instead, one could use annotation parameter estimates from RolyPoly with tissue-or celltype-specific gene expression to calculate h gene j trait importance values and prioritize genes within the local GWAS region. Additionally, as we have shown, our method can identify significantly associated tissues, which one could prioritize for collection of population samples for eQTL analysis.
and use the definition of Pearson's correlation coefficient once again by relying on the fact that the genotype matrix has been scaled and centered, , and single-cell-based cell-type clusters from the human brain dataset. 39 Range specifies the empirical bounds of the 95% confidence interval. Estimates highlighted in red represent significant associations (p < 0.05).
A B Figure 6 . RolyPoly-Inferred Model Parameters Predict DE Genes in the Prefrontal Cortex (PFC) of Individuals with AD (A) Differential-expression test statistics (a larger value represents genes that are upregulated in the brains of affected individuals) were significantly larger in the set of genes specifically expressed in the microglia cell type than in a control gene set (right). We define the set of cell-type-specific genes as the top 10% specifically expressed genes. We compared them with the control gene set, which includes genes that deviate the least from average gene expression. The differential-expression test statistic was not enriched in genes specifically expressed in the fetal quiescent cell type (left). and the differentialexpression test statistic was evaluated with a null distribution generated from simulations, which accounted for the gene expression covariance structure (full details of this test can be found in the Material and Methods).
In the Material and Methods, we write the above expression with matrix notation. Others have described a similar relationship among estimated effects, LD, and the true effect sizes. 83 
Derivation of Distribution Parameters of Effect Estimates
Here, we describe the mean and variance of the estimated SNP effects by using our polygenic model. The expected value is computed as follows,
and because we model the genetic and environmental effects with normal distributions with mean 0, we conclude that E½ b
where D refers to the diagonal matrix of SNP effect-size variances; in the second equality, we use the fact that R ¼ R T . We use these values of the expectation and variance to parameterize the multivariate normal distribution that describes the estimated GWAS effect sizes.
Derivation of Expected SNP Variance
Note that the distribution of the squared [ 2 norm of a random vector drawn from a multivariate normal distribution with mean 0 is the trace of the covariance matrix. 36, 84 Thus, the expected value of the sum of squared SNP effect sizes near gene j is given by
We derive this by using the linearity of the trace and recalling that R is a correlation matrix, and hence the diagonal elements are 1. When SNP annotations are included, we model the expected value of the squared marginal SNP effect size. The marginal distribution of the squared SNP effect size around gene j is b b i $ Nð0; s Relationship to Previous Work Rewriting (RDR) ii as P i 0 n i 0 r 2 ii 0 and substituting quantitative feature values with an indicator function that signifies whether a SNP is within a discrete annotation class, we arrive at an equation similar to the basic LD Score regression model,
Note that we go from the first to the second line by substituting n from Equation 3. Although the models share some similarities, our model is derived independently to utilize the full quantitative data from single-cell gene expression assays.
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